---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-035842"
form_type: "8-K"
ticker: "INFU"
cik: "0001337013"
company_name: "InfuSystem Holdings, Inc"
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T10:44:47.269163+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# InfuSystem Q2 net revenue $33.7M (record), net income $0.7M (+65% YoY); reaffirms FY24 high-single-digit growth

## Summary
- Net revenues $33.7M (+6% YoY); net income $0.7M ($0.03 diluted EPS) vs $0.4M ($0.02) prior year.
- Patient Services rev $20.2M (+5%), Device Solutions $13.5M (+8%); overall gross margin 49.5% (down 0.4%).
- Adjusted EBITDA $6.1M (18.0% margin), up 5.4% YoY; operating cash flow $2.7M (+17%).
- Device Solutions gross margin fell 8.1% to 24.0% due to $0.6M error correction and unfavorable mix.
- Reaffirmed FY24 guidance: high-single-digit revenue growth, Adjusted EBITDA margin in high-teens.

## SEC filing metadata
- accession: 0001628280-24-035842
- form_type: 8-K
- ticker: INFU
- cik: 0001337013
- company_name: InfuSystem Holdings, Inc
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1337013/000162828024035842/0001628280-24-035842-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1337013/000162828024035842/infu-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-035842
- JSON: https://secwatch.observer/filing/0001628280-24-035842.json
- Plain text: https://secwatch.observer/filing/0001628280-24-035842.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.